Search

everythinglearnresearchcommunity

for

Search:↓

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Removing part of the vitamin D receptor stops vitamin D from working properly.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Vitamin D receptor helps prevent skin tumors.

Vitamin D receptor may help protect against UV-induced skin cancer.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

ΔNp63α helps control a protein that stops cancer cells from spreading.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

The vitamin D receptor can regulate genes and affect hair and hormone levels without its usual activator.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.